Meckler Jeffrey A Insider Trading Activity

Average Profitability
21.71%
Insider Buys Quantity
14
Insider Buys Sum
$1.37M
Insider Sells Quantity
1
Insider Sells Sum
$562,324.00

Insider Activity of Meckler Jeffrey A

According to the SEC Form 4 filings, Meckler Jeffrey A, being in a position of

  1. director at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 28000 shares for $1.71M,
    over all time since 2014-11-25, has bought 60000 shares for $700,228, and sold 68000 shares for $2.27M.

Biography of Meckler Jeffrey A

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,706,1062100

Comparison of Insiders on Amount of Buys and Sells

2026-09-10SaleTravere Therapeutics, Inc.
TVTX
director
20,000
0.0214%
$67.31$1.35M-20.97%
2026-05-04SaleTravere Therapeutics, Inc.
TVTX
director
8,000
0.0087%
$45.00$360,000+25.34%
2024-09-30SaleTravere Therapeutics, Inc.
TVTX
director
40,000
0.0489%
$14.06$562,324+28.31%
2022-11-21PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
9,600
0.122%
$1.90$18,240+4.97%
2022-11-18PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
400
0.0047%
$1.76$705+4.97%
2022-09-08PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
10,308
0.1329%
$2.80$28,862-29.66%
2022-09-06PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
8,632
0.1092%
$2.57$22,184-24.8%
2022-06-06PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
19,727
0.2371%
$2.63$51,882-28.68%
2021-11-18PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
11,187
0.2847%
$5.82$65,108-44.81%
2021-09-14PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
12,000
0.2842%
$7.00$84,000-43.28%
2016-03-15PurchaseCocrystal Pharma, Inc.
COCP
294,118
0.0353%
$0.51$150,000-22.95%
2016-03-04PurchaseTravere Therapeutics, Inc.
TVTX
director
10,000
0.0282%
$15.31$153,129+24.34%
2016-03-03PurchaseTravere Therapeutics, Inc.
TVTX
director
20,000
0.0545%
$14.45$289,000+27.31%
2015-12-23PurchaseCocrystal Pharma, Inc.
COCP
100,000
0.0151%
$0.58$57,870-3.64%
2015-03-25PurchaseCocrystal Pharma, Inc.
COCP
163,043
0.0216%
$0.92$150,000-22.77%
2014-12-11PurchaseCocrystal Pharma, Inc.
COCP
200,000
0.0151%
$0.23$45,610+88.64%
2014-11-25PurchaseTravere Therapeutics, Inc.
TVTX
director
30,000
0.1058%
$8.60$258,099+147.72%
Total: 17
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.